News & Media


​​​​ImmunOs Therapeutics AG closes 2.3 Million Financing to Support Lead Clinical Candidate Program Acceleration
Read Article

ImmunOs Therapeutics AG appoints Pamela Carroll, Ph.D., a Leading Industry and Academic Oncology Drug Discovery Expert to the Scientific Advisory Board 
Read Article

ImmunOs Therapeutics AG Partners with Locust Walk to Support Business Development Activities for their Novel Innate and Adaptive Immunotherapy Platform for Cancer 

Read Article​

ImmunOs Therapeutics AG appoints Leading U.S. Based Academic and Industry Oncology, Immunology, and Product Development Experts to the Scientific Advisory Board

Read Article                                                                                                                                                                                                                          

ImmunOs Therapeutics AG appoints Sean R. Smith as new Chief Executive Officer and Dr. Osiris Marroquin-Belaunzaran as Chief Scientific Officer Read Article